This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Healthy
and you are a man who is
between 18 and 55
years old
Phase
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

Study in healthy males to assess bioavailability of single fostamatinib with iv micro tracer dose.

Provided treatments

  • Drug: Fostamatinib
  • Drug: Fostamatinib
Tris trial is registered with FDA with number: NCT01598571. The sponsor of the trial is AstraZeneca and it is looking for 37 volunteers for the current phase.
Official trial title:
A Study to Assess the Absolute Bioavailability of a Single Oral Dose of Fostamatinib With Respect to an Intravenous Micro Tracer Dose of [14C] R406 in Healthy Male Volunteers